New data from Eli Lilly says its daily, oral GLP-1 pill may help people who have obesity and people who have Type 2 diabetes ...

The latest results from a trial of a pill form popular GLP-1 medications offer enough information for the Eli Lilly to ...

GLP-1 patches for weight loss have made the scene—but a leading MD warns you they aren't the same as the more familiar ...

Studies have linked GLP-1 medications to various eye conditions, some of which may lead to vision loss. Despite these ...

Drugmaker Eli Lilly says its oral, daily GLP-1 pill may offer similar weight loss results as weekly GLP-1 shots. Eli Lilly, the maker of Mounjaro and Zepbound, said Thursday that the company's new ...

Compounded GLP-1s helped people continue treatment while brand-name GLP-1 injections were in shortage. But they’re not meant to be a long-term solution when FDA-approved options are available.

People using GLP-1 medications aren’t just ‘taking the easy way out.’ You’ve probably seen someone online make the accusation, so-and-so lost weight, they must be taking Ozempic — cheater.

In fact, about 1 in 8 Americans have taken a GLP-1 drug at some point in their life, according to KFF health. Drugs like Ozempic and Mounjaro are highly effective at curbing pounds.

More adults are taking GLP-1 drugs to control their weight, despite recent shortages and high list prices, according to new research. The percentage of overweight or obese adults prescribed a GLP ...

GLP-1 receptor agonists, a class of drug used to treat type 2 diabetes, likely trump the widely prescribed metformin for curbing dementia risk in people with the condition, finds the largest study ...

3. On GLP-1 drugs, get comfortable with being uncomfortable The great thing about these drugs, says Kessler, is that they allow you to relearn how to eat. But that comes with some caveats.

Drugmaker Eli Lilly says its daily oral GLP-1 pill may help people who have obesity and people with Type 2 diabetes lose ...